• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

224镭治疗强直性脊柱炎患者远期效应的随访研究。

Follow-up study of late effects in 224Ra treated ankylosing spondylitis patients.

作者信息

Wick R R, Gössner W

出版信息

Health Phys. 1983;44 Suppl 1:187-95. doi: 10.1097/00004032-198306001-00015.

DOI:10.1097/00004032-198306001-00015
PMID:6862898
Abstract

We are following 1531 patients treated with 224Ra from 14 hospitals in the F.R.G. and 267 control patients with ankylosing spondylitis not treated with any form of ionizing radiation. Since 1970 three cases of malignant tumour in the skeleton have been found among 224Ra-treated patients with skeletal doses below 90 rad compared with 0.4-0.6 expected. Two of these three cases were tumours of the bone marrow. An effect of 224Ra on the haematopoietic system cannot be excluded. Also, seven cases of cataract were found among 274 224Ra patients. The mean time since 224Ra treatment was 26 yr. The mean age at diagnosis was 66 yr. The cataract incidence was not unusual for people of this age.

摘要

我们正在跟踪德国14家医院中接受224镭治疗的1531名患者,以及267名未接受任何形式电离辐射治疗的强直性脊柱炎对照患者。自1970年以来,在骨骼剂量低于90拉德的接受224镭治疗的患者中,发现了3例骨骼恶性肿瘤,而预期为0.4 - 0.6例。这3例中的2例是骨髓肿瘤。不能排除224镭对造血系统的影响。此外,在274名接受224镭治疗的患者中发现了7例白内障。自接受224镭治疗后的平均时间为26年。诊断时的平均年龄为66岁。这个年龄段的人群白内障发病率并无异常。

相似文献

1
Follow-up study of late effects in 224Ra treated ankylosing spondylitis patients.224镭治疗强直性脊柱炎患者远期效应的随访研究。
Health Phys. 1983;44 Suppl 1:187-95. doi: 10.1097/00004032-198306001-00015.
2
224Ra: risk to bone and haematopoietic tissue in ankylosing spondylitis patients.镭-224:强直性脊柱炎患者骨骼和造血组织所面临的风险
Strahlentherapie Sonderb. 1985;80:38-44.
3
Bone sarcoma cumulative tumor rates in patients injected with 224Ra.注射224Ra的患者的骨肉瘤累积肿瘤发生率。
Strahlentherapie Sonderb. 1985;80:27-31.
4
Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment.给强直性脊柱炎患者施用较低剂量镭-224 不会导致明显的整体损害。
PLoS One. 2020 Apr 30;15(4):e0232597. doi: 10.1371/journal.pone.0232597. eCollection 2020.
5
Late effects in ankylosing spondylitis patients treated with 224Ra.接受224镭治疗的强直性脊柱炎患者的晚期效应。
Radiat Res. 1999 Dec;152(6 Suppl):S8-S11.
6
Cataracts in patients injected with 224Ra.接受224镭注射的患者中的白内障。
Strahlentherapie Sonderb. 1985;80:51-9.
7
Soft-tissue effects following 224Ra injections into humans.
Health Phys. 1978 Jul;35(1):61-81. doi: 10.1097/00004032-197807000-00006.
8
Incidence of leukaemia and other malignant diseases following injections of the short-lived alpha-emitter 224Ra into man.向人体注射短寿命α发射体224镭后白血病及其他恶性疾病的发病率
Radiat Environ Biophys. 2009 Aug;48(3):287-94. doi: 10.1007/s00411-009-0227-y. Epub 2009 May 28.
9
Long-term clinical investigation of patients with ankylosing spondylitis treated with 224Ra.对接受224镭治疗的强直性脊柱炎患者的长期临床研究。
Health Phys. 1983;44 Suppl 1:197-202. doi: 10.1097/00004032-198306001-00016.
10
The biological effects of radium-224 injected into dogs.注射到狗体内的镭-224的生物学效应。
Radiat Res. 1996 Aug;146(2):171-86.

引用本文的文献

1
Incidence of leukaemia and other malignant diseases following injections of the short-lived alpha-emitter 224Ra into man.向人体注射短寿命α发射体224镭后白血病及其他恶性疾病的发病率
Radiat Environ Biophys. 2009 Aug;48(3):287-94. doi: 10.1007/s00411-009-0227-y. Epub 2009 May 28.
2
Ankylosing spondylitis: an overview.强直性脊柱炎:概述
Ann Rheum Dis. 2002 Dec;61 Suppl 3(Suppl 3):iii8-18. doi: 10.1136/ard.61.suppl_3.iii8.
3
Possible cataractogenic effect of radionuclides deposited within the eye from the blood stream.
放射性核素从血流中沉积在眼内可能产生的致白内障作用。
Br J Ophthalmol. 1985 Mar;69(3):219-27. doi: 10.1136/bjo.69.3.219.